White paper: Are misaligned incentives preventing better patient outcomes in life sciences R&D?
Collaborative white paper highlights misaligned incentives in R&D are holding back full human data integration and better patient outcomes.
Pistoia Alliance Appoints Dr. Christian Baber as New Chief Portfolio Officer and Launches 2024 Project Pipeline
Innovative projects will tackle social media “listening,” AI ethics and security, measuring the carbon footprint of clinical trials, and publishing industry-specific ontologies for R&D Boston, 10th January 2024: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has appointed Dr Christian Baber as its new Chief Portfolio Officer. […]
Pistoia Alliance Partners with Matador in Japan
Partnership will boost adoption of new technologies, and unlock Japan’s R&D expertise on areas including targeted immunotherapy, the human microbiome, and neurology Boston, 14th June 2023: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced a new partnership with Matador Japan KK, experts in the Japanese […]
Pistoia Alliance Publishes Free Guide to Accelerate the Implementation of FAIR Principles in Clinical Data
Pistoia Alliance Expands Diversity & Inclusion Leadership Program to Offer Rare Cross-Industry Collaboration Opportunity and Encourage Industry Transformation
Pistoia Alliance Launches New Community of Experts to Use Social Media Insights to Drive Patient-Centric Drug Development
Boston, US, November 17, 2022: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) to harness real-world data from social media. The CoE aims to develop best practices and guidelines to use social media analysis as real-world data (RWD) for […]
Pistoia Alliance Completes First Phase of Identification of Medicinal Product Ontology Project to Aid Compliance Ahead of EMA’s 2023 Regulation Deadline
Boston, US, 2 November 2022: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has completed the first phase of its IDMP Ontology project. The project supports companies in complying with the upcoming implementation by the European Medicines Agency (EMA) of the five IDMP standards set by the […]
Pistoia Alliance Launches Global Community of Interest to Assess the Environmental Impact of Clinical Trials
Boston, US, 11 October 2022: The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the launch of the Clinical Trials Environmental Impact Community of Interest (CoI) to measure and compare the carbon footprint of centralized (traditional site-based) and decentralized clinical trials. The initiative was started by […]
Pistoia Alliance and FDA Collaborate to Establish In Vitro Pharmacology Working Group to Accelerate Regulatory Submissions
Boston, US, September 13, 2022: The Pistoia Alliance a global not-for-profit that advocates for greater collaboration in life sciences R&D, has today announced the creation of a new In Vitro Pharmacology Working Group. The group will include liaisons from the US Food and Drug Administration’s Center for Drug Evaluation and Research, as well as representatives […]